CP-866087

N/A

Report date: 2023/10/11 09:09:35
NME

Base Information

Drug NameCP-866087
Drug Alias NameCP-866087
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor antagonists
TargetsMu opioid receptor
Therapy Area/IndicationsAlcoholismObesitySexual Dysfunction, Physiological
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenNorway +[6] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsAlcoholismObesitySexual Dysfunction, Physiological

Other Information

ATC CodeN/A
Related LinksN/A